11-66562261-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001104.4(ACTN3):​c.2327A>G​(p.Gln776Arg) variant causes a missense change. The variant allele was found at a frequency of 0.555 in 1,613,402 control chromosomes in the GnomAD database, including 253,659 homozygotes. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.61 ( 29593 hom., cov: 30)
Exomes 𝑓: 0.55 ( 224066 hom. )

Consequence

ACTN3
NM_001104.4 missense

Scores

1
9

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 3.67

Publications

53 publications found
Variant links:
Genes affected
ACTN3 (HGNC:165): (actinin alpha 3) This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.3758257E-7).
BP6
Variant 11-66562261-A-G is Benign according to our data. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-66562261-A-G is described in CliVar as Benign. Clinvar id is 3060488.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.785 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTN3NM_001104.4 linkc.2327A>G p.Gln776Arg missense_variant Exon 19 of 21 ENST00000513398.2 NP_001095.2 Q08043B4DZQ2
ACTN3NM_001258371.3 linkc.2456A>G p.Gln819Arg missense_variant Exon 19 of 21 NP_001245300.2 Q08043A0A087WSZ2B4DZQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTN3ENST00000513398.2 linkc.2327A>G p.Gln776Arg missense_variant Exon 19 of 21 1 NM_001104.4 ENSP00000426797.1 Q08043
ACTN3ENST00000502692.5 linkc.2456A>G p.Gln819Arg missense_variant Exon 19 of 21 2 ENSP00000422007.1 A0A087WSZ2

Frequencies

GnomAD3 genomes
AF:
0.611
AC:
92763
AN:
151730
Hom.:
29542
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.792
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.549
Gnomad EAS
AF:
0.534
Gnomad SAS
AF:
0.417
Gnomad FIN
AF:
0.688
Gnomad MID
AF:
0.579
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.582
GnomAD2 exomes
AF:
0.533
AC:
132907
AN:
249310
AF XY:
0.533
show subpopulations
Gnomad AFR exome
AF:
0.790
Gnomad AMR exome
AF:
0.330
Gnomad ASJ exome
AF:
0.562
Gnomad EAS exome
AF:
0.552
Gnomad FIN exome
AF:
0.679
Gnomad NFE exome
AF:
0.558
Gnomad OTH exome
AF:
0.529
GnomAD4 exome
AF:
0.549
AC:
802611
AN:
1461552
Hom.:
224066
Cov.:
66
AF XY:
0.547
AC XY:
397433
AN XY:
727058
show subpopulations
African (AFR)
AF:
0.804
AC:
26912
AN:
33480
American (AMR)
AF:
0.344
AC:
15366
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
14482
AN:
26134
East Asian (EAS)
AF:
0.514
AC:
20395
AN:
39698
South Asian (SAS)
AF:
0.427
AC:
36843
AN:
86258
European-Finnish (FIN)
AF:
0.673
AC:
35898
AN:
53312
Middle Eastern (MID)
AF:
0.537
AC:
3090
AN:
5758
European-Non Finnish (NFE)
AF:
0.554
AC:
616323
AN:
1111824
Other (OTH)
AF:
0.552
AC:
33302
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
22456
44913
67369
89826
112282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17288
34576
51864
69152
86440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.612
AC:
92863
AN:
151850
Hom.:
29593
Cov.:
30
AF XY:
0.611
AC XY:
45314
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.792
AC:
32785
AN:
41392
American (AMR)
AF:
0.445
AC:
6785
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.549
AC:
1902
AN:
3466
East Asian (EAS)
AF:
0.534
AC:
2747
AN:
5142
South Asian (SAS)
AF:
0.418
AC:
2009
AN:
4808
European-Finnish (FIN)
AF:
0.688
AC:
7276
AN:
10574
Middle Eastern (MID)
AF:
0.582
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
0.553
AC:
37578
AN:
67904
Other (OTH)
AF:
0.576
AC:
1214
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1736
3472
5207
6943
8679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
105877
Bravo
AF:
0.602
TwinsUK
AF:
0.555
AC:
2057
ALSPAC
AF:
0.554
AC:
2136
ESP6500AA
AF:
0.786
AC:
3316
ESP6500EA
AF:
0.550
AC:
4656
ExAC
AF:
0.542
AC:
65594
Asia WGS
AF:
0.498
AC:
1731
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

ACTN3-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
16
DANN
Benign
0.81
DEOGEN2
Benign
0.21
T;T
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.33
T;T
MetaRNN
Benign
9.4e-7
T;T
PhyloP100
3.7
PrimateAI
Uncertain
0.63
T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
.;B
Vest4
0.022
GERP RS
5.7
Varity_R
0.048
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540874; hg19: chr11-66329732; COSMIC: COSV59747900; COSMIC: COSV59747900; API